Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Head/Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05054439
What this trial is testing

A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 45
Testing effectiveness (Phase 2)UnknownNCT02145312
What this trial is testing

An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.

Who this might be right for
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Yonsei University 43
Early research (Phase 1)Study completedNCT03474640
What this trial is testing

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Who this might be right for
Advanced Malignancies
TopAlliance Biosciences 184
Testing effectiveness (Phase 2)Study completedNCT04742959
What this trial is testing

Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCholangiocarcinomaHER2-negative Breast Cancer+8 more
TransThera Sciences (Nanjing), Inc. 203
Testing effectiveness (Phase 2)Study completedNCT01534585
What this trial is testing

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Taizhou Hospital 48
Testing effectiveness (Phase 2)UnknownNCT05394415
What this trial is testing

Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaTislelizumabChemoradiation
Jiangsu Cancer Institute & Hospital 30
Not applicableStudy completedNCT02147418
What this trial is testing

Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Cancer
New Mexico Cancer Research Alliance 15
Not applicableUnknownNCT00918710
What this trial is testing

Human Papillomavirus and Oropharynx Carcinoma

Who this might be right for
Oropharyngeal Neoplasms
Assistance Publique - Hôpitaux de Paris 362
Not applicableLooking for participantsNCT07718620
What this trial is testing

HPV-associated Oropharyngeal Carcinoma (HPV-OPC)

Who this might be right for
Oropharyngeal Carcinoma (OPC)
Masaryk Memorial Cancer Institute 35
Not applicableStudy completedNCT05557955
What this trial is testing

Identification of Breath Biomarkers in Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Mian XI 210
Early research (Phase 1)Looking for participantsNCT06902376
What this trial is testing

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerThyroid CancerBRAF Mutation-Related Tumors
UNC Lineberger Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT06323460
What this trial is testing

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Oropharyngeal Squamous Cell Carcinoma
Ohio State University Comprehensive Cancer Center 45
Not applicableUnknownNCT03093649
What this trial is testing

Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 320
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07388758
What this trial is testing

Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 37
Testing effectiveness (Phase 2)Ended earlyNCT00423150
What this trial is testing

Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)

Who this might be right for
Colorectal NeoplasmHead and Neck NeoplasmCarcinoma, Non-Small-Cell Lung+1 more
Merck Sharp & Dohme LLC 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT07010120
What this trial is testing

A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
HNSCCLysogenic HSV VirusNeoadjuvant Therapy+2 more
West China Hospital 29
Early research (Phase 1)Active Not RecruitingNCT04470024
What this trial is testing

Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

Who this might be right for
Cancer of the Head and Neck
Providence Health & Services 19
Not applicableStudy completedNCT04606940
What this trial is testing

Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)

Who this might be right for
Head and Neck CancerAdvanced CancerMetastatic Cancer+2 more
University Health Network, Toronto 18
Not applicableUnknownNCT04158518
What this trial is testing

De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Chaosu Hu 118
Testing effectiveness (Phase 2)Ended earlyNCT01267240
What this trial is testing

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Paranasal Sinus Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+14 more
National Cancer Institute (NCI) 25
Next Page